Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01212965 · ClinicalTrials.gov registry record · Phase 1
Selenium in the Treatment of Complicated Lymphatic Malformations
A Phase 1 study, sponsored by Medical College of Wisconsin.
- Terminated
- Registry status
- Phase 1
- Development phase
- 5
- Enrollment target
NCT01212965 is a Phase 1 study that was terminated before completion, run by Medical College of Wisconsin. The registered enrollment target is 5 participants.
The verdict
NCT01212965, a Phase 1 study, was terminated before completion, sponsored by Medical College of Wisconsin.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 5 participants
- Enrollment target
Study Summary
The investigators propose a pilot trial to obtain preliminary information regarding the safety and response rate of patients with symptomatic lymphatic malformations treated with oral Selenium. Information obtained in this pilot trial will be used to plan future phase 2 clinical trials. Hypotheses: * Selenium will be safe and efficacious in the treatment of adolescents and young adults with symptomatic lymphatic malformations * Disease response will correlate with serum levels of selenium and blood levels of antioxidants essential to selenium metabolism.
Interventions
- DRUG Selenium
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2010-09 |
| Est. Completion | 2012-11 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01212965
The ClinicalTrials.gov registry entry for NCT01212965 describes a study currently listed as terminated, categorized as Phase 1. The registered enrollment target is 5 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medical College of Wisconsin, which has 447 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Selenium is the first listed.
NCT01212965 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01212965 about?
NCT01212965 is a clinical study titled "Selenium in the Treatment of Complicated Lymphatic Malformations". The investigators propose a pilot trial to obtain preliminary information regarding the safety and response rate of patients with symptomatic lymphatic malformations treated with oral Selenium. Information obtained in this pilot trial will be used to plan future phase 2 clinical trials. Hypotheses:...
What is the current status of trial NCT01212965?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 5 participants. The study started on 2010-09. Estimated completion is 2012-11.
What interventions are being tested in trial NCT01212965?
The interventions under investigation include: Selenium (DRUG).
Who is sponsoring clinical trial NCT01212965?
This trial is sponsored by Medical College of Wisconsin, which has 447 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.